How COVID mRNA vaccines may make cancer treatments more effective
A new study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint therapy in lung and skin cancers…
New drug combination shows promise in treating colorectal cancer
Colorectal cancer is one of the most common tumors among people over the age of 50. Although it…
Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapy
Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice…
Strong grip strength lowers risk of organ dysfunction in obesity
People with obesity who also have high muscle mass may be less likely to have obesity-related organ damage.…
Caraway seeds inspire new seizure-fighting medicines
A UNLV-led team of researchers has co-opted a common kitchen spice to create a new class of cannabidiol…
UC Irvine develops human-like colon model for precision medicine
Researchers at the University of California, Irvine have developed a 3D human colon model integrated with bioelectronics to…
UCSF team uncovers breakthrough immunotherapy for colon cancer liver metastases
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest…
Engineered Salmonella therapy delivers immune payloads to combat cancer
A new research paper was published in Volume 16 of Oncotarget on October 6, 2025, titled “ACTM-838, a novel systemically delivered…
Highly targeted gene therapy could revolutionize treatment for cancers linked to herpesvirus
In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could…
Genetic modification enhances “living drugs” for blood cancers
CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…
Glucose-fructose mix found in sugary drinks fuels colorectal cancer metastasis
A new study from researchers at The University of Texas MD Anderson Cancer Center shows that the glucose-fructose…
New NIH grant supports development of experimental pediatric HIV vaccine
A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from…